America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
When index levels rise, adjust allocations gradually and monitor sectors leading the move. This intro provides simple steps to respond without overreacting.
19,220 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A Bernstein Research note argues Bitcoin has likely formed a cycle bottom and pins a $450 target on Strategy stock, s...
Dow's Jim Fitterling cautions that the Iran war is disrupting petrochemical supply, potentially fueling inflation thr...
EQT Corp is becoming a cash machine, with free cash flow rising and margins expanding. Wall Street is warming to the ...
The latest consumer sentiment 56.4 reading sets the tone for retail stocks and the VanEck Retail ETF (RTH) in 2026. I...
Ethereum climbs on a market rebound after a golden cross formation sparks bullish chatter. Analysts say the setup cou...
A veteran tech founder eyes a decade of tax-free living as markets shift. Experts outline a four-bucket plan using 0%...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...
A major fund reportedly dumped million in Netskope stock after the cloud-security name sank about half from its IPO l...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
A new voter poll shows broad demand for federal action to reduce housing costs, with cross‑party support for quick pa...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...